Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > NanoBioMagnetics Announces Issuance of US Patent

Abstract:
Officials of NanoBioMagnetics, Inc., (NBMI) today announced the issuance of its first patent by the U.S. Patent and Trademark Office. The patent, titled "Method and Apparatus for Improving Hearing," is based on the use of magnetically responsive nanoparticles implanted in the organs of the middle ear to drive tissue vibrations in the amplification of sound.

NanoBioMagnetics Announces Issuance of US Patent

Edmond, OK | Posted on March 24th, 2008

The technology was the first demonstration of the nanomechanical movement of tissue and operates in
principle much like a typical commercial electromagnetic hearing aid. Development and validation was
done during 2002 - 2004. The company now will move the technology through commercialization
partnerships.

Statistics of the National Institutes of Health indicate sensorineural hearing loss affects approximately 28 million Americans. The technology covered by today's patent has the potential to move hearing aid systems to smaller and totally implantable hearing devices, achieving more favorable patient economics, performance and compliance.

Charles Seeney, CEO and Founder of NBMI, and co-inventor on the patent, said "miniaturization of
hearing devices through ever smaller electronic components is part of an emerging trend based on
applying nanotechnology to human healthcare needs." A companion technology, based on the targeted
delivery of bioactive materials to the inner ear, continues under development. The company also has in progress major research collaborations assessing the tumor-specific delivery of cancer therapeutics, research for which is ongoing at the M D Anderson Cancer Center in Houston.

NBMI is a nanobiomaterials company, with core technology focused on designed structures of
magnetically responsive nanoparticles to cause or drive a desired physiological event. Its healthcare technologies are developed and validated through collaborations with academic and industrial institutions. NBMI's hearing amplification technology was developed in part through collaborations with the University of Oklahoma and the Massachusetts Eye and Ear Infirmary, an affiliate of Harvard Medical School.

Today's issuance is viewed as Oklahoma's first nanotechnology-based patent for a healthcare
application.


####

About NanoBioMagnetics, Inc.
NanoBioMagnetics (NBMI) is a nanobiomaterials company pioneering an emerging area of nanomedicine referred to as organ-assisting-device (OAD) technologies. The company has developed a targeted therapeutic delivery methodology in which designed configurations of magnetically responsive nanoparticles (MNP), under the influence of external shaped magnetic fields, cause or drive a desired physiological event. MNP, single domain and superparamagnetic, respond to an applied magnetic field, returning to their normal state when the field is removed, in effect creating a "biomagnetic" switch. The company is applying this technological concept to a range of human health applications in collaborations with major research institutions across the country, where several scientific "firsts" have been achieved and published.

For more information, please click here

Contacts:
Charles E Seeney
(405) 844-5118

Copyright © NanoBioMagnetics, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Virginia Tech physicists propose path to faster, more flexible robots: Virginia Tech physicists revealed a microscopic phenomenon that could greatly improve the performance of soft devices, such as agile flexible robots or microscopic capsules for drug delivery May 17th, 2024

Gene therapy relieves back pain, repairs damaged disc in mice: Study suggests nanocarriers loaded with DNA could replace opioids May 17th, 2024

Shedding light on perovskite hydrides using a new deposition technique: Researchers develop a methodology to grow single-crystal perovskite hydrides, enabling accurate hydride conductivity measurements May 17th, 2024

Oscillating paramagnetic Meissner effect and Berezinskii-Kosterlitz-Thouless transition in cuprate superconductor May 17th, 2024

Nanomedicine

Virginia Tech physicists propose path to faster, more flexible robots: Virginia Tech physicists revealed a microscopic phenomenon that could greatly improve the performance of soft devices, such as agile flexible robots or microscopic capsules for drug delivery May 17th, 2024

Diamond glitter: A play of colors with artificial DNA crystals May 17th, 2024

Advances in priming B cell immunity against HIV pave the way to future HIV vaccines, shows quartet of new studies May 17th, 2024

New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024

Announcements

Virginia Tech physicists propose path to faster, more flexible robots: Virginia Tech physicists revealed a microscopic phenomenon that could greatly improve the performance of soft devices, such as agile flexible robots or microscopic capsules for drug delivery May 17th, 2024

Diamond glitter: A play of colors with artificial DNA crystals May 17th, 2024

Finding quantum order in chaos May 17th, 2024

Oscillating paramagnetic Meissner effect and Berezinskii-Kosterlitz-Thouless transition in cuprate superconductor May 17th, 2024

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project